Search - tctmd.com

Displaying 241 - 260 of 685

Sort: Relevancy | Date

Presentation TCT 2017

TAVR for Severe AS and Chronic Kidney Disease

Presenter: Gregory P. Fontana, Saif Anwaruddin

November 01, 2017

Presentation TCT 2017

Aortic Arch Electrical Stimulation for Heart Failure

Presenter: Jozef Bartunek

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

Presenter: Gregory P. Fontana, Alexander Lauten

November 01, 2017

Presentation TCT 2017

The Potential for Neuromodulation in Heart Failure

Presenter: Felix Mahfoud

November 01, 2017

Presentation TCT 2017

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Presenter: Gregory P. Fontana, Julinda Mehilli

November 01, 2017

Presentation TCT 2017

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

Presenter: Navin K. Kapur

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS With a Small Aortic Annulus

Presenter: Gregory P. Fontana, Josep Rodés-Cabau

November 01, 2017

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Presenter: Gregory P. Fontana, Amar Krishnaswamy

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Presentation TCT 2017

Next Generation Bio Innovation

Presenter: Andreu M Climent, Amit N. Patel

October 31, 2017

Presentation TCT 2017

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Presenter: Andreu M Climent, Amit N. Patel, Angel Arenal

October 31, 2017

Presentation TCT 2017

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

Presenter: Andreu M Climent, Amit N. Patel, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

Presenter: Andreu M Climent, Amit N. Patel, Gary L. Schaer

October 31, 2017

Presentation TCT 2017

Case Presentation: Valve-in-Ring

Presenter: Mayra Guerrero, John G. Webb, Ganesh Manoharan

October 31, 2017

Presentation TCT 2017

Valve-in-Ring: Patient Selection, Technical Pearls, and Outcomes

Presenter: Mayra Guerrero, John G. Webb, Danny Dvir

October 31, 2017

Presentation TCT 2017

Case Presentation: Valve-in-Valve

Presenter: Mayra Guerrero, John G. Webb, Brian K. Whisenant

October 31, 2017

Presentation TCT 2017

Valve-in-Valve: Patient Selection, Technical Pearls, and Outcomes

Presenter: Mayra Guerrero, John G. Webb, Isaac George

October 31, 2017

Presentation TCT 2017

Case Presentation: Valve-in-MAC

Presenter: Mayra Guerrero, John G. Webb, Isaac George

October 31, 2017

$My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!$

Presentation TCT 2017

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Presenter: Timothy D. Henry, Marc S. Penn

October 31, 2017

Advertisement

TAVR for Severe AS and Chronic Kidney Disease

Aortic Arch Electrical Stimulation for Heart Failure

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

The Potential for Neuromodulation in Heart Failure

TAVR for Low-gradient AS (Normal and Reduced LVEF) Diagnosis and Management

Devices for Cardio-Renal Failure: The Future of Heart Failure and Shock Therapies?

TAVR for Severe AS With a Small Aortic Annulus

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Next Generation Bio Innovation

Heterogeneous Tissue Is Most Important! Reduction of the Substrate for Ventricular Arrhythmias Will Have Better Impact on Cardiovascular Mortality

Focal Reduction of Scar to Reduce Ventricular Arrhythmias

The Clinical Point of View: The Need for and Challenges of Regenerative Strategies to Reduce Sudden Death

Case Presentation: Valve-in-Ring

Valve-in-Ring: Patient Selection, Technical Pearls, and Outcomes

Case Presentation: Valve-in-Valve

Valve-in-Valve: Patient Selection, Technical Pearls, and Outcomes

Case Presentation: Valve-in-MAC

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content